UniProt ID | TNR21_HUMAN | |
---|---|---|
UniProt AC | O75509 | |
Protein Name | Tumor necrosis factor receptor superfamily member 21 | |
Gene Name | TNFRSF21 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 655 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . |
|
Protein Description | Promotes apoptosis, possibly via a pathway that involves the activation of NF-kappa-B. Can also promote apoptosis mediated by BAX and by the release of cytochrome c from the mitochondria into the cytoplasm. Plays a role in neuronal apoptosis, including apoptosis in response to amyloid peptides derived from APP, and is required for both normal cell body death and axonal pruning. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). N-APP binds TNFRSF21; this triggers caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6). Negatively regulates oligodendrocyte survival, maturation and myelination. Plays a role in signaling cascades triggered by stimulation of T-cell receptors, in the adaptive immune response and in the regulation of T-cell differentiation and proliferation. Negatively regulates T-cell responses and the release of cytokines such as IL4, IL5, IL10, IL13 and IFNG by Th2 cells. Negatively regulates the production of IgG, IgM and IgM in response to antigens. May inhibit the activation of JNK in response to T-cell stimulation.. | |
Protein Sequence | MGTSPSSSTALASCSRIARRATATMIAGSLLLLGFLSTTTAQPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHLPWMIVLFLLLVLVVIVVCSIRKSSRTLKKGPRQDPSAIVEKAGLKKSMTPTQNREKWIYYCNGHGIDILKLVAAQVGSQWKDIYQFLCNASEREVAAFSNGYTADHERAYAALQHWTIRGPEASLAQLISALRQHRRNDVVEKIRGLMEDTTQLETDKLALPMSPSPLSPSPIPSPNAKLENSALLTVEPSPQDKNKGFFVDESEPLLRCDSTSSGSSALSRNGSFITKEKKDTVLRQVRLDPCDLQPIFDDMLHFLNPEELRVIEEIPQAEDKLDRLFEIIGVKSQEASQTLLDSVYSHLPDLL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MGTSPSSSTAL ----CCCCCCHHHHH | 19.63 | - | |
13 | Phosphorylation | SSSTALASCSRIARR CHHHHHHHHHHHHHH | 17.30 | - | |
22 | Phosphorylation | SRIARRATATMIAGS HHHHHHHHHHHHHHH | 22.35 | - | |
24 | Phosphorylation | IARRATATMIAGSLL HHHHHHHHHHHHHHH | 12.54 | - | |
82 | N-linked_Glycosylation | YVSEHCTNTSLRVCS EECCCCCCCCEEEEC | 32.82 | 19654028 | |
141 | N-linked_Glycosylation | PPGMFQSNATCAPHT CCCCCCCCCCCCCCC | 28.61 | 19654028 | |
177 | Phosphorylation | QCARGTFSDVPSSVM HHCCCCCCCCCHHHH | 37.22 | - | |
181 | Phosphorylation | GTFSDVPSSVMKCKA CCCCCCCHHHHHCHH | 35.10 | - | |
182 | Phosphorylation | TFSDVPSSVMKCKAY CCCCCCHHHHHCHHH | 21.84 | - | |
227 | O-linked_Glycosylation | STSPSPGTAIFPRPE CCCCCCCEEEECCCC | 21.69 | OGP | |
252 | N-linked_Glycosylation | TYVPKGMNSTESNSS CCCCCCCCCCCCCCC | 55.22 | 19654028 | |
253 | Phosphorylation | YVPKGMNSTESNSSA CCCCCCCCCCCCCCC | 25.35 | 24114839 | |
254 | Phosphorylation | VPKGMNSTESNSSAS CCCCCCCCCCCCCCC | 38.13 | 24114839 | |
256 | Phosphorylation | KGMNSTESNSSASVR CCCCCCCCCCCCCCC | 41.94 | 24114839 | |
257 | N-linked_Glycosylation | GMNSTESNSSASVRP CCCCCCCCCCCCCCH | 33.48 | 19654028 | |
261 | Phosphorylation | TESNSSASVRPKVLS CCCCCCCCCCHHHHH | 22.17 | 24114839 | |
268 | Phosphorylation | SVRPKVLSSIQEGTV CCCHHHHHHHHCCCC | 28.51 | 29978859 | |
269 | Phosphorylation | VRPKVLSSIQEGTVP CCHHHHHHHHCCCCC | 24.91 | 29978859 | |
274 | Phosphorylation | LSSIQEGTVPDNTSS HHHHHCCCCCCCCCC | 28.28 | 29978859 | |
278 | N-linked_Glycosylation | QEGTVPDNTSSARGK HCCCCCCCCCCCCCH | 35.47 | 19654028 | |
289 | N-linked_Glycosylation | ARGKEDVNKTLPNLQ CCCHHHHHHHCCCCE | 43.87 | 19654028 | |
291 | O-linked_Glycosylation | GKEDVNKTLPNLQVV CHHHHHHHCCCCEEC | 42.09 | OGP | |
315 | Phosphorylation | HILKLLPSMEATGGE HHHHHHHHCEECCCC | 29.26 | 22985185 | |
315 | O-linked_Glycosylation | HILKLLPSMEATGGE HHHHHHHHCEECCCC | 29.26 | OGP | |
319 | Phosphorylation | LLPSMEATGGEKSST HHHHCEECCCCCCCC | 32.20 | 22985185 | |
368 | S-palmitoylation | VLVVIVVCSIRKSSR HHHHHHHHHHHHCCC | 1.62 | 19654028 | |
376 | Phosphorylation | SIRKSSRTLKKGPRQ HHHHCCCCCCCCCCC | 44.89 | - | |
386 | Phosphorylation | KGPRQDPSAIVEKAG CCCCCCHHHHHHHHC | 38.63 | 30576142 | |
397 | Phosphorylation | EKAGLKKSMTPTQNR HHHCCCCCCCCCCCH | 26.71 | 23312004 | |
399 | Phosphorylation | AGLKKSMTPTQNREK HCCCCCCCCCCCHHH | 30.21 | 23312004 | |
401 | Phosphorylation | LKKSMTPTQNREKWI CCCCCCCCCCHHHEE | 29.34 | 23312004 | |
409 | Phosphorylation | QNREKWIYYCNGHGI CCHHHEEEEECCCCC | 10.80 | - | |
410 | Phosphorylation | NREKWIYYCNGHGID CHHHEEEEECCCCCH | 3.13 | - | |
434 | Phosphorylation | GSQWKDIYQFLCNAS CCCHHHHHHHHHCCC | 11.89 | - | |
460 | Phosphorylation | TADHERAYAALQHWT CCHHHHHHHHHHHCE | 9.91 | 28442448 | |
514 | Phosphorylation | DKLALPMSPSPLSPS CCCCCCCCCCCCCCC | 21.93 | 23090842 | |
516 | Phosphorylation | LALPMSPSPLSPSPI CCCCCCCCCCCCCCC | 31.03 | 23403867 | |
519 | Phosphorylation | PMSPSPLSPSPIPSP CCCCCCCCCCCCCCC | 27.07 | 23403867 | |
521 | Phosphorylation | SPSPLSPSPIPSPNA CCCCCCCCCCCCCCC | 31.89 | 23403867 | |
525 | Phosphorylation | LSPSPIPSPNAKLEN CCCCCCCCCCCCCCC | 31.35 | 23403867 | |
533 | Phosphorylation | PNAKLENSALLTVEP CCCCCCCCCCEEECC | 15.77 | 28176443 | |
537 | Phosphorylation | LENSALLTVEPSPQD CCCCCCEEECCCCCC | 24.55 | 30108239 | |
541 | Phosphorylation | ALLTVEPSPQDKNKG CCEEECCCCCCCCCC | 22.99 | 29255136 | |
545 | Acetylation | VEPSPQDKNKGFFVD ECCCCCCCCCCCCCC | 56.14 | 19823529 | |
547 | Acetylation | PSPQDKNKGFFVDES CCCCCCCCCCCCCCC | 63.94 | 19823537 | |
547 | Ubiquitination | PSPQDKNKGFFVDES CCCCCCCCCCCCCCC | 63.94 | - | |
554 | Phosphorylation | KGFFVDESEPLLRCD CCCCCCCCCCCEECC | 39.80 | 23090842 | |
562 | Phosphorylation | EPLLRCDSTSSGSSA CCCEECCCCCCCCCH | 33.54 | 23090842 | |
563 | Phosphorylation | PLLRCDSTSSGSSAL CCEECCCCCCCCCHH | 17.41 | 23090842 | |
564 | Phosphorylation | LLRCDSTSSGSSALS CEECCCCCCCCCHHH | 36.33 | 23090842 | |
565 | Phosphorylation | LRCDSTSSGSSALSR EECCCCCCCCCHHHH | 42.66 | 23090842 | |
567 | Phosphorylation | CDSTSSGSSALSRNG CCCCCCCCCHHHHCC | 17.87 | 23090842 | |
568 | Phosphorylation | DSTSSGSSALSRNGS CCCCCCCCHHHHCCC | 36.43 | 23090842 | |
571 | Phosphorylation | SSGSSALSRNGSFIT CCCCCHHHHCCCCCC | 24.34 | 23090842 | |
575 | Phosphorylation | SALSRNGSFITKEKK CHHHHCCCCCCHHCC | 19.61 | 28102081 | |
578 | Phosphorylation | SRNGSFITKEKKDTV HHCCCCCCHHCCCCE | 31.01 | 28102081 | |
584 | Phosphorylation | ITKEKKDTVLRQVRL CCHHCCCCEEEEECC | 30.25 | 23532336 | |
648 | Phosphorylation | QTLLDSVYSHLPDLL HHHHHHHHHHCCCCC | 8.37 | 25884760 | |
649 | Phosphorylation | TLLDSVYSHLPDLL- HHHHHHHHHCCCCC- | 19.18 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TNR21_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNR21_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNR21_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRADD_HUMAN | TRADD | physical | 9714541 | |
MATR3_HUMAN | MATR3 | physical | 21900206 | |
STX11_HUMAN | STX11 | physical | 21900206 | |
PSMD4_HUMAN | PSMD4 | physical | 24829148 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...